A Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group, 2-part Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Inhaled Doses of AZD9819 in Healthy Subjects.

Trial Profile

A Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group, 2-part Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Inhaled Doses of AZD9819 in Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Nov 2011

At a glance

  • Drugs AZD 9819 (Primary)
  • Indications Asthma
  • Focus Adverse reactions
  • Most Recent Events

    • 25 May 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Sep 2010 Actual initiation date (Aug 2010) added as reported by ClinicalTrials.gov.
    • 15 Sep 2010 Planned end date changed from 1 Dec 2010 to 1 Jan 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top